Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Smokeless Tobacco and Cigar and/or Pipe Are Risk Factors for Barrett Esophagus in Male Patients With Gastroesophageal Reflux Disease.

Westra WM, Lutzke LS, Mostafavi NS, Roes AL, Calpe S, Wang KK, Krishnadath KK.

Mayo Clin Proc. 2018 Sep;93(9):1282-1289. doi: 10.1016/j.mayocp.2018.04.022.

PMID:
30193675
2.

microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.

Mari L, Hoefnagel SJM, Zito D, van de Meent M, van Endert P, Calpe S, Sancho Serra MDC, Heemskerk MHM, van Laarhoven HWM, Hulshof MCCM, Gisbertz SS, Medema JP, van Berge Henegouwen MI, Meijer SL, Bergman JJGHM, Milano F, Krishnadath KK.

Gastroenterology. 2018 Sep;155(3):784-798. doi: 10.1053/j.gastro.2018.06.030. Epub 2018 Jun 7.

PMID:
29885883
3.

Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus.

Martinez P, Timmer MR, Lau CT, Calpe S, Sancho-Serra Mdel C, Straub D, Baker AM, Meijer SL, Kate FJ, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Bergman JJ, Maley CC, Graham TA, Krishnadath KK.

Nat Commun. 2016 Aug 19;7:12158. doi: 10.1038/ncomms12158.

4.

Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing Cholangitis.

Timmer MR, Lau CT, Meijer SL, Fockens P, Rauws EA, Ponsioen CY, Calpe S, Krishnadath KK.

Gastroenterol Res Pract. 2016;2016:4381513. doi: 10.1155/2016/4381513. Epub 2016 Apr 3.

5.

Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.

Calpe S, Correia AC, Sancho-Serra Mdel C, Krishnadath KK.

MAbs. 2016 May-Jun;8(4):678-88. doi: 10.1080/19420862.2016.1158380.

6.

Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies.

Calpe S, Wagner K, El Khattabi M, Rutten L, Zimberlin C, Dolk E, Verrips CT, Medema JP, Spits H, Krishnadath KK.

Mol Cancer Ther. 2015 Nov;14(11):2527-40. doi: 10.1158/1535-7163.MCT-14-0956. Epub 2015 Sep 8.

7.

Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.

Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK.

Gut. 2016 Oct;65(10):1602-10. doi: 10.1136/gutjnl-2015-309642. Epub 2015 Jun 23.

8.

Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study.

Davelaar AL, Calpe S, Lau L, Timmer MR, Visser M, Ten Kate FJ, Parikh KB, Meijer SL, Bergman JJ, Fockens P, Krishnadath KK.

Genes Chromosomes Cancer. 2015 Feb;54(2):82-90. doi: 10.1002/gcc.22220. Epub 2014 Oct 4.

PMID:
25284618
9.

Immune signaling and regulation in esophageal cancer.

Calpe S, Compare D, Mari L, Nardone G, Parikh K.

Ann N Y Acad Sci. 2014 Sep;1325:15-22. doi: 10.1111/nyas.12518.

PMID:
25266011
10.

Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.

Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath KK.

Front Oncol. 2013 May 29;3:137. doi: 10.3389/fonc.2013.00137. eCollection 2013.

11.

Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load.

West EE, Youngblood B, Tan WG, Jin HT, Araki K, Alexe G, Konieczny BT, Calpe S, Freeman GJ, Terhorst C, Haining WN, Ahmed R.

Immunity. 2011 Aug 26;35(2):285-98. doi: 10.1016/j.immuni.2011.05.017.

12.

Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity.

Brown DR, Calpe S, Keszei M, Wang N, McArdel S, Terhorst C, Sharpe AH.

J Immunol. 2011 Jul 1;187(1):21-5. doi: 10.4049/jimmunol.1100510. Epub 2011 May 27.

13.

A novel isoform of the Ly108 gene ameliorates murine lupus.

Keszei M, Detre C, Rietdijk ST, Muñoz P, Romero X, Berger SB, Calpe S, Liao G, Castro W, Julien A, Wu YY, Shin DM, Sancho J, Zubiaur M, Morse HC 3rd, Morel L, Engel P, Wang N, Terhorst C.

J Exp Med. 2011 Apr 11;208(4):811-22. doi: 10.1084/jem.20101653. Epub 2011 Mar 21.

14.

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Keszei M, Latchman YE, Vanguri VK, Brown DR, Detre C, Morra M, Arancibia-Carcamo CV, Paul E, Calpe S, Castro W, Wang N, Terhorst C, Sharpe AH.

Int Immunol. 2011 Feb;23(2):149-58. doi: 10.1093/intimm/dxq465. Epub 2011 Jan 28. Erratum in: Int Immunol. 2011 Jul;23(7):463. Arancibia, Carolina V [corrected to Arancibia-Carcamo, Carolina V].

15.

Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse.

Wang N, Calpe S, Westcott J, Castro W, Ma C, Engel P, Schatzle JD, Terhorst C.

J Immunol. 2010 Nov 15;185(10):5683-7. doi: 10.4049/jimmunol.1001974. Epub 2010 Oct 20.

16.

The SLAM and SAP gene families control innate and adaptive immune responses.

Calpe S, Wang N, Romero X, Berger SB, Lanyi A, Engel P, Terhorst C.

Adv Immunol. 2008;97:177-250. doi: 10.1016/S0065-2776(08)00004-7. Review.

PMID:
18501771
17.

Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters.

Calpe S, Erdos E, Liao G, Wang N, Rietdijk S, Simarro M, Scholtz B, Mooney J, Lee CH, Shin MS, Rajnavölgyi E, Schatzle J, Morse HC 3rd, Terhorst C, Lanyi A.

Immunogenetics. 2006 Feb;58(1):15-25. Epub 2006 Feb 16.

PMID:
16425036
18.

Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.

Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D, Rietdijk S, Thompson A, Coyle AJ, Denny C, Yaffe MB, Engel P, Eck MJ, Terhorst C.

EMBO J. 2001 Nov 1;20(21):5840-52.

19.

Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.

Morra M, Silander O, Calpe S, Choi M, Oettgen H, Myers L, Etzioni A, Buckley R, Terhorst C.

Blood. 2001 Sep 1;98(5):1321-5.

PMID:
11520777
20.

Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.

Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C.

J Biol Chem. 2001 Sep 28;276(39):36809-16. Epub 2001 Jul 26.

Supplemental Content

Support Center